Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pulmonary > Neoplastic Diseases > Flashcards

Neoplastic Diseases Flashcards

1
Q

pulmonary nodule info

A

Definition: ≤ 3 cm isolated, rounded opacity on chest xray
- Commonly: Incidental finding with no clinical symptom
- ⅓ of all nodule findings are noted on CT scans ordered for other things
-Not associated with infiltrate, atelectasis, or adenopathy
-Most benign nodules = infectious granulomas
-Importance: pulmonary nodles carries a significant risk of malignancy
–

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most benign nodules =_______ granulomas

A

infectious granulomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do we do about a pulmonary nodule benign vs malignant

A

Malignant Tumors: Resection if indicated
- Nodules with a high index of suspicion for malignancy may warrant resection
-CT is indicated in any suspicious solitary pulmonary nodule!

Benign Tumors: Avoid invasive procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lung cancer screening: Fleischner Society guidlines

A

Annual screening = LOW DOSE computed tomography (LDCT):
- adults aged 50 to 80 years AND
- have a 20 pack-year smoking history or quit smoking within 15 years
-dont screen if they have have a health problem that lowers life expectancy

-Change in criteria expanded eligible population ->
detecting large numbers of lung nodules (majority benign)

2022 “State of Lung Cancer” report: only 5.8% of eligible Americans have been screened for lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors for nodule malignancy

A

Age:
- < 30, malignant tumors are rare
- Risk ↑ with age

Smokers:
- Likelihood of malignancy ↑↑↑ with pack-years (20+ yrs)

Hx of Malignancy:
- Hx ↑ likelihood of further malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Evaluation of Malignant Tumors: size of nodule

A

Mild: 2-5 mm = 1% Malignancy
Moderate: 6-10 mm = 24% Malignancy
Significant: 11-20 mm = 33% Malignancy
Severe: 21-45 mm = 80% Malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Evaluation of Malignant Tumors: what factors

A

Factors that make nodules more likely malignant:

-Doubling time: rapid progression
-Size: large size
-Borders: ill defined margins, lobular, spiculated margins, peripheral halo
-Calcification: NO calcifications or sparse -> dense calcifications indicate prior inflammation
- cavitation: can be infectious or malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Evaluation of Malignant Tumors: borders of nodule

A

Benign: Smooth, well-defined edge

Malignant:
- Ill-defined margins or lobular appearance
- Spiculated margins and peripheral halo

Lobulated: malignancy
Cavitary: could be infectious or malignancy
Spiculated BAC: hazy
Smooth Granuloma: Beningn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Evaluation of Malignant Tumors: Doubling Time

A

Rapid progression (< 30 days) is suggestive of infectious process

Long term stability (> 500 days) suggests benignity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Evaluation of Malignant Tumors: calcifications

A

Benign lesions: Dense calcification
- calcification suggests prior inflammation

Malignant lesions: Sparser calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

nodule tx: Low probability of malignancy (<5%)

A

Features of low probability:
-Age under 30
-Characteristic pattern of benign calcification: small, not growing, dense, well defined borders, etc

Tx = Watchful waiting!!!! + serial CTs at routine intervals
-Serial CT scans: with growth would suggest malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is this calcified vs not

A

Calcified nodule! incidental finding on chest xray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

nodule tx: high probability (>60%) of malignancy

A

Resect nodule if no contraindications

if its large, spiculated + peripheral halo = high probability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

nodule tx: intermediate probability of malignancy (5-60%)

A

5-60% = intermediate

Bx:
- transthoracic needle aspiration (TTNA)
- bronchoscopy
PET/CT: shows metabolic activity - + test could be infection or inflammation
Sputum cytology:
- highly specific but useless unless central lesion

Video-assisted thoracoscopic surgery (VATS):
- aggressive approach to dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

carcinoid tumors: definition + location

A

Definition:
- Low grade malignant neoplasm with a slow growth rate and rare metastasis chance
- “Cancer-ish”: Does not behave like regular lung cancer
- Typically < 60 years old patients-> YOUNGER

Location:
- Central Bronchi (MC): Sessile or Pedunculated growths
- Peripherally Located: Asymptomatic solitary pulmonary nodule (rare)

“CARcinoid tumor = only people under 60 should drive a car -> younger age because they are the CENTRAL part of society
Cars = SPEed -> SEssile or PEdunculated”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

carcinoid tumors: S&S

A

-Hemoptysis
-Cough
-Focal wheezing
-Recurrent pneumonia

CARCinoid Syndrome: rare
- Cutatneous Flushing
- Asthmatic Wheezing
- Rapid HR/Hypotension
- Cramping/Diarrhea
- Due to the substances that the carcinoid secretes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

carcinoid tumor dx

A

Bronchoscopy:
-PINK or PURPLE tumor in a central airway

CT scanning:
- localizes the lesion
- use to follow growth over time

Octreotide Scintigraphy, Dotatate PET/CT Scan:
- Localize region of metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

carcinoid tumor tx + complications

A

Surgical excision*
Bronchoscopic removal if:
- entirely endoluminal
- poor surgical candidate

Prognosis is generally favorable

Complication:
- Bleeding and airway obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

bronchogenic carcinoma description

A

Lung cancer: #1 cause of cancer deaths in men and women!!!
-Cigarette smoking causes > 85% of cases of lung ca
-Mean age at diagnosis 70
- Unusual under the age 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

bronchogenic carcinoma risk factors

A

-Tobacco smoke**
-Radon gas
-Asbestos
-Metals
-Industrial carcinogens
-Family Hx
-Medical conditions
-Previous primary lung cancer
–

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

bronchogenic carcinoma: 4 histologic types

A
  • Squamous cell carcinoma (20%)
  • Adenocarcinoma (38% - MC) -> Bronchoalveolar cell carcinoma (2%)
  • Large cell carcinoma (5%)
    -Small cell carcinoma (13%)

For staging purposes, classifications are split into Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

bronchogenic carcinoma: Small Cell Lung Cancer (SCLC) vs NSCLC

A

SCLC: small cell carcinoma
-Prone to early hematogenous spread
-Rarely amenable to surgical resection
-Very aggressive course with median survival (untreated) of 6–18 weeks

NSCLC:
-Spreads more slowly
-May be cured in early stages following resection
-Respond similarly to chemotherapy
-includes: SCC, Adenocarcinoma (Bronchoalveolar cell carcinoma), Large cell carcinoma

23
Q

bronchogenic carcinoma: squamous cell carcinoma

A

Origin: BRONCHIAL epithelium
Starts off as centrally located, intraluminal sessile/polypoid mass

Descripton
-common sx: hemoptysis
-Spreads locally
-More frequently dx with sputum cytology-> DR VAFAIE DX with cytology BX
- hypercalcemia from paraneoplastic syndromes

24
Q

bronchogenic carcinoma: adenocarcinoma (MC)

A

Origin: MUCUS glands
- Found in nonsmokers *
- Presents as peripheral nodules/masses *

Bronchoalveolar Cell Carcinoma:
- Spreads intra-alveolar
- May present as infiltrate or as single/multiple pulmonary nodules
- Radiographically looks like pneumonia
- Paraneoplastic: thromboplebitis

25
bronchogenic carcinoma: large cell carcinoma
-heterogeneous group of relatively undifferentiated tumors that share large cells and do not fit into other categories -Typically have RAPID doubling times and an aggressive clinical course -They present as central OR peripheral masses --
26
bronchogenic carcinoma: small cell carcinoma
Origin: Bronchial - typically begins CENTRALLY* - Infiltrating SUBMUCOSALLY -> narrowing or obstruction of the bronchus without a obvious luminal mass - Since submucosal -> hard to biopsy - Metastasizes early + is aggressive -Very aggressive course with median survival of 6-18 weeks - Prone to early hematogenous spread Results in rarely amenable to surgical resection "SMALL cell = SUBmucosal -> this is hard to bx -> hard to treat"
27
clinical picture
-Type and location of the primary tumor -Extent of local spread -Presence of distant metastases -Paraneoplastic syndromes --
28
paraneoplastic syndromes
Carcinoid tumors may oftentimes secrete substances to cause Paraneoplastic Syndromes Hypercalcemia = SCC Endocrine issues = Small cell Neuromuscular issues = small cell Cardiovascular = adenocarcinoma Hematological = all Gynecomastia = large cell
29
lung cancer symptoms
Early stage lung cancers: asymptomatic If symptoms present, malignancy has progressed to advanced stage = worse prognosis Typical symptoms include: - wt loss - SOB - hemoptysis -cough
30
lung cancer complications
-SVC syndrome - Pancoast's tumor: tumor of the lung apex; horner's syndrome* -exudative pleural effusion - hoarseness: recurrent laryngeal - carcinoid syndrome
31
superior vena cava syndrome
-tumor obstructing SVC -facial edema and plethora -venous distension distal to obstruction --
32
horner’s syndrome
Problem with sympathetic nerve supple to one side of face: - tumor invades sympathetic trunk -> unilateral sx Sx: -miosis- constriction -ptosis- droopy eyelid -anhidrosis- failure to sweat --
33
How to dx lung cancer
Dx = tissue or sputum/fluid cytology -Thoracentesis* -FNA*: palpable supraclavicular or cervical nodes -Bronchoscopy: 10-90% yield -Transthoracic needle bx with CT: -Video assisted thoracoscopic surgery (VATS): only if above fails -Mediastinoscopy
34
Tumor markers of lung cancer
-PDL1 -ALK gene -EGFR gene Tumor markers: complement bx; not definitive
35
Where can lung cancers metastize to?
Liver or brain
36
Staging of Non Small Cell Lung Cancers
Stages are 1-4; with 4 being the worst Stage is determined by looking at 3 separate components T= Tumor size N= Lymph Node involvement M= Absence or presence of metastastis
37
new tx for NSCLC: immunotherapy
Definition: Use of medicines to help a Pt’s immune system recognize and destroy cancer cells - Functions by blocking PD-1 or PDL-1 = T cells can now recognize tumor cells -> increases immune response = slows tumor progression - Immunotherapy greatly helps recognize cancer as foreign Specific blocking sites: -PD-1 Blockers: -PDL-1 Blockers: Tumor marker: PDL1!!
38
immunotherapies: PD-1 and PDL-1
Target PD-1: "NP" -Nivolumab (Opdivo) -Pembrolizumab (Keytruda) Target PDL-1: "MD - more letters (PDL), more schooling than NPs" -Mezolizumab (Tecentriq) -Durvalumab (Imfinzi) ------ Block receptor on tumor cells -> tumor is recognized as foreign -> body immune system works to destroy cancer
39
Targeted therapy tx for specific mutations in lung cancer
EGFR directed therapy - immunotherapy helped prolong life in these pts
40
staging of SCLC
Limited Disease Definition: - Disease confined to ipsilateral hemithorax and within a single radiotherapy port Extensive Disease Definition: - Evident metastatic disease OUTSIDE the ipsilateral hemithorax ---- SCLC: is usually disseminated in almost all pts
41
tx of SCLC: limited stage
- COMBO of chemotherapy and radiation therapy - Surgery is NOT indicated unless there is a solitary pulmonary nodule without metastasis - 12-15%: 5-Year Survival Rate
42
tx of SCLC: extensive stage
tx: - Chemotherapy ONLY as initial therapy - If responsive, then add radiation - 2% 5-Year Survival Rate
43
metastatic lung cancer
Definition: Spread of any cancer to lungs through vascular or lymphatic channels or by direct extension -Metastases usually through the pulmonary artery -Typically present as MULTIPLE nodules or masses on chest radiography - most are intraparenchymal (in alveoli/bronchioles; areas of gas exchange) - less common is endobronchial - MC: kidney, breast, colon cervix, and malignant melanomas. "think of the pulm artery as a catapult that shoots the cannonballs into the lungs and then lands in the lower ung zones, intraparenchymal because the alveoli are also the balls (cannonball)"
44
Most likely primary tumor in metastatic lung ds
Most likely: - kidney - breast - colon -cervix - malignant melanoma
45
metastatic lung cancer symptoms
MC = ASYMPTOMATIC May present with: -Cough, hemoptysis -Dyspnea and hypoxemia (advanced) -Symptoms are more often referable to the site of the PRIMARY tumor
46
metastatic lung cancer imaging
CT = most sensitive * Chest radiographs: - multiple spherical densities with sharp margins -MC: lower lung zones Image: endotracheal metastases (growth in trachea)
47
what type of cancer is this?
Metastatic lung cancer with MULTIPLE round lesions - CANNONBALL LESIONS - multiple spherical densities with sharp margins - usually at the bases - CT more sensitive than x-ray this is very progressed ds -> pt would be symptomatic "cannonballs need to land bc of gravity so they are in the bases/lower lung zones"
48
metastatic lung cancer dx
Usually established by identifying the primary tumor If hx and PE fail to reveal the site of the primary tumor: TAKE LUNG TISSUE SAMPLE - bronchoscopy - percutaneous needle biopsy - thoracotomy: incision into the chest; major surgery
49
metastatic lung cancer tx
1st: treat primary neoplasm and any pulmonary complications 2nd: Surgical resection of SOLITARY pulmonary nodule if: - Primary tumor controlled - Good surgical candidate - All metastatic tumors can be resected - No other metastasize ------ The overall 5-year survival rate in secondary lung cancer treated surgically is 20–35%
50
Contraindications to surgical resection in metastatic lung cancer
-Melanoma -Pleural involvement - Multiple metastasis
51
What is the first step in the treatment protocol for potentially resectable NSCLC?
Initial evaluation to determine the clinical stage of the cancer.
52
What approach is advised for patients with clinical stage III NSCLC?
multidisciplinary approach - consultation with medical oncology, thoracic surgery, - consideration of chemotherapy, surgery, or induction therapy followed by resection.
53
After resection of the NSCLC tumor, what determines the next steps in treatment? and what are the tx options?
Pathologic staging of the cancer - pathologic stage 1a: Observation - pathologic stage Ib, II, III: adjuvant chemotherapy
54
What is the preferred treatment for NSCLC patients who are not surgical candidates but have tumors less than 5 cm?
SBRT (stereotactic body radiation therapy).

Pulmonary (23 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions